DATROWAY® (datopotamab deruxtecan-dlnk) has been approved in the U.S. for the treatment of adult patients with unresectable or metastatic hormone receptor (HR) positive, HER2 negative (IHC 0, IHC 1+ ...

DXd, has been approved in the US for the treatment of adult patients with unresectable or metastatic hormone receptor HR-positive, HER2-negative breast cancer who have received prior endocrine-based ...

But many existing models fall short of adhering to established best practices for economic evaluation, the review authors ...

Sex-related differences in pulmonary complications were found among men vs women with SSc, specifically in the prevalence of ILD and SAD.

Pivotal Study Demonstrated the Combination More Than Doubled Progression-Free Survival Compared to Investigated SOC THOUSAND OAKS, Calif., Jan. 17, 2025 /PRNewswire/ ...

The following is a summary of “An exploratory analysis of differences in serum protein expression by sex in patients with ...

It will provide care for a group of disorders that may progress to pulmonary fibrosis. Asian Hospital and Medical Centre ...

Idiopathic Pulmonary Fibrosis (IPF) is a chronic interstitial lung disease characterized by progressive scarring of lung ...

IMVARIA Inc., a health tech company pioneering AI-driven digital biomarker solutions, today announced its second FDA authorization, securing 510(k) clearance from the U.S. Food and Drug Administration ...

The Company continues to anticipate that the totality of its early-stage research programs will comprise less than 20% of overall expenditure.

Analyst Serge Belanger of Needham maintained a Buy rating on Liquidia Technologies (LQDA – Research Report), retaining the price target of ...